optimizing public neoantigen-targeting immunotherapies
Published 2 years ago • 160 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
2:30
targeting public neoantigens in cancer immunotherapies
-
4:20
utilizing neoantigen-specific tcrs for personalized immunotherapies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
7:23
success principles of cancer immunotherapy
-
4:15
decoding cancer immunology: hunting hidden tumours
-
3:35
epigenomics in precision oncology
-
3:26
genomic determinants of resistance in patients with ndmm treated with targeted immunotherapy
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
5:22
novel target antigens to improve the efficacy of immunotherapeutics in multiple myeloma
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
1:51
targeting complement to treat pnh and other hematologic diseases
-
1:41
transplant optimization strategies
-
1:12
an update in cellular therapies: gene editing for scd and immunotherapies for mm
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
0:45
difference between quality of life & patient-reported outcomes
-
0:52
tocilizumab for aa amyloidosis
-
1:04
overcoming the limits to widespread ngs implementation
-
2:09
heart transplantation in attr amyloidosis